Biohit
3
EUR
-4.15 %
Corporate customer
BIOBV
NASDAQ Helsinki
Medical Equipment & Services
Health Care
4,824 following
-4.15%
+29.31%
+31%
+22.95%
+27.66%
+55.44%
+67.6%
-27.88%
-42.31%
Biohit is a medical technology company. The company develops and manufactures laboratory equipment, supplies, and diagnostic analysis systems adapted for research, care, and industrial laboratories. In addition to the main activities, technical support, maintenance, and training services are offered within the mentioned work area. The largest presence is in the Nordic market. The company is headquartered in Helsinki.
Read moreMarket cap
45.54M EUR
Turnover
11.41K EUR
P/E (adj.) (24e)
19.44
EV/EBIT (adj.) (24e)
15.63
P/B (24e)
3.8
EV/S (24e)
2.65
Dividend yield-% (24e)
-
Revenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
12/2
2025
Annual report '24
4/6
2025
General meeting '25
6/8
2025
Interim report Q2'25
Risk
Business risk
Valuation risk
Low
High
ShowingAll content types
New distribution rights for Biohit
BIOHIT secures European distribution rights for Biomedal’s gluten immunogenic peptide tests
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools